Quantum Genomics releases its 2022 financial results and provides an update on its M&A discussions Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC) today announces its results for the ful...
Quantum Genomics is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure.